Skip to main content
Wednesday, July 24, 2024 - 1:04pm
Fiserv Inc

Fiserv reported strong Q2 results with revenue increasing by 7% Y/Y to $5.11B, beating analyst estimates. Adjusted EPS of $2.13 also beat expectations. Fiserv reiterated its FY24 outlook with organic revenue growth of 15-17% and raised adjusted EPS outlook. Stock gained 21% in last 12 months.

Read more
Wednesday, July 24, 2024 - 1:03pm
vertiv_smartrow-2br-config1_front_800x600

Vertiv Holdings reported strong Q2 FY24 results with 57% organic orders growth, 13% net sales growth, and 63% operating profit growth. Adjusted EPS beat consensus. Increased AI deployment and operational execution drove performance.

Read more
Wednesday, July 24, 2024 - 12:48pm
Tesla EVs.

Eight Tesla analysts weigh in on Q2 results and what's ahead for the automotive and technology company.

Read more
Wednesday, July 24, 2024 - 12:44pm
analysis-4937349

Azitra shares are crashing Wednesday after the company announced the pricing of a $10 million public offering of 6,665,000 common shares and Class A warrants at $1.50 per share.

Read more
News, Movers
Wednesday, July 24, 2024 - 12:34pm
Spotify

Spotify reports strong Q2 results, exceeding expectations for gross margins, operating income, and free cash flows. Analysts raise rating and price targets.

Read more
Wednesday, July 24, 2024 - 12:27pm
What's Going On With Mullen Automotive Stock?

Mullen Automotive shares decline as it secures order from GAMA for 29 micro urban delivery vehicles amid broader market challenges.

Read more
Wednesday, July 24, 2024 - 12:26pm
2024 Ford Ranger

Ford is expected to release quarterly financial earnings today after the market closes.

Read more
News, Movers
Wednesday, July 24, 2024 - 12:23pm
Visa

Visa's stock fell after reporting Q3 results. Analysts express concern around the company's core business.

Read more
Wednesday, July 24, 2024 - 12:12pm
cybersecurity

The Trading Desk, among other companies in the ad tech industry, may be reacting to Google's decision to keep third-party cookies.

Read more
News, Movers
Wednesday, July 24, 2024 - 12:10pm
BZ Pharma Briefs

Pfizer's Phase 3 AFFINE study of giroctocogene fitelparvovec gene therapy for hemophilia A meets key endpoints, showing a significant reduction in annualized bleeding rate.

Read more